Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Single-Treatment Efficacy and Safety Study of MYOBLOC® Followed by Open-Label, Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects

NCT01994109 is registered in ClinicalTrials.gov with Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC as lead sponsor.

NCT NCT01994109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01994109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Single-Treatment Efficacy and Safety Study of MYOBLOC® Followed by Open-Label, Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects
Lead sponsor
Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2013
Completion date
January 31, 2017
Enrollment
187 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

sialorrhea